You are about to exit for another SJM country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
today’s conversation on PULSE, the St. Jude Medical blog.
At St. Jude Medical, responsible and visionary clinical leadership is a key part of our goal of reducing the cost of health care and lessening the impact of disease on patients and their families. To that end, we:
Our clinical studies in the focus areas of cardiac arrhythmias, heart failure, cardiovascular disease, structural heart, chronic pain and movement disorders span the continuum from early feasibility testing and premarket approval to postmarket studies that support clinical practice guidelines and enhance patient access to appropriate medical care.
Our work yields game-changing results with life-changing implications, building the body of evidence needed to support the long-term safety, effectiveness and cost-savings of our innovative technologies.
Recent studies include:
*This therapy is not approved by the FDA for use in the United States. Limited by federal (or U. S.) law to investigational use. Commercially available for use in select international markets